These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3020325)

  • 41. Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain.
    Ori C; Ford-Rice F; London ED
    Anesthesiology; 1989 Mar; 70(3):541-4. PubMed ID: 2564264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid analgesia in the mouse: evidence for multiple receptors using beta-FNA.
    Sánchez-Blázquez P; Garzón J
    NIDA Res Monogr; 1986; 75():465-8. PubMed ID: 2828993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of naloxone on nitrous oxide actions in healthy volunteers.
    Zacny JP; Conran A; Pardo H; Coalson DW; Black M; Klock AP; Klafta JM
    Pain; 1999 Dec; 83(3):411-418. PubMed ID: 10568848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
    Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
    Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord.
    Zhang C; Davies MF; Guo TZ; Maze M
    Anesthesiology; 1999 Nov; 91(5):1401-7. PubMed ID: 10551592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonged exposure to nitrous oxide decreased opiate receptor density in rat brainstem.
    Ngai SH; Finck AD
    Anesthesiology; 1982 Jul; 57(1):26-30. PubMed ID: 6283950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    Pick CG; Paul D; Pasternak GW
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanisms of the analgesic actions of opiates and opioids.
    Dickenson AH
    Br Med Bull; 1991 Jul; 47(3):690-702. PubMed ID: 1665377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors.
    Quock RM; Best JA; Chen DC; Vaughn LK; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1990 Jan; 175(1):97-100. PubMed ID: 2157601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The possibility that nitrous oxide at analgesic concentrations is an opiate receptor agonist.
    Gilmann MA
    SAAD Dig; 1984 Apr; 5(10):244-8. PubMed ID: 6087477
    [No Abstract]   [Full Text] [Related]  

  • 55. Stereospecific reversal of nitrous oxide analgesia by naloxone.
    Moody EJ; Mattson M; Newman AH; Rice KC; Skolnick P
    Life Sci; 1989; 44(11):703-9. PubMed ID: 2927240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE; Pelton JT; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo.
    D'Amato R; Holaday JW
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2898-901. PubMed ID: 6326151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
    Omote K; Kitahata LM; Nakatani K; Collins JG
    Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.